Category
All
New Technology
Service & Software
Internet & Communication
Electronics & Semiconductor
Pharma & Healthcare
Other
Energy & Power
Agriculture
Consumer Goods
Machinery & Equipment
Food & Beverages
Medical Care
Automobile & Transportation
Packaging
Chemical & Material
Medical Devices & Consumables
Category
All
Total: 3 records, 1 pages
Search For: Erythropoietin Stimulating Agents
Global Erythropoietin Stimulating Agents Market 2024 by Company, Regions, Type and Application, Forecast to 2030
10 Jan 2024
Medical Care
Erythropoietin Stimulating Agents
According to our (Global Info Research) latest study, the global Erythropoietin Stimulating Agents market size was valued at USD 9197.8 million in 2023 and is forecast to a readjusted size of USD 12120 million by 2030 with a CAGR of 4.0% during review period.
USD3480.00
Add To Cart
Global Erythropoietin Stimulating Agents Supply, Demand and Key Producers, 2023-2029
16 Feb 2023
Medical Care
Erythropoietin Stimulating Agents
Erythropoiesis-stimulating agents (ESA) are medications which stimulate the bone marrow to make red blood cells. They are used to treat anemia due to end stage kidney disease, chemotherapy, major surgery, or certain treatments in HIV/AIDS.
USD4480.00
Add To Cart
Global Erythropoietin Stimulating Agents Market 2023 by Company, Regions, Type and Application, Forecast to 2029
09 Jan 2023
Medical Care
Erythropoietin Stimulating Agents
Erythropoiesis-stimulating agents (ESA) are medications which stimulate the bone marrow to make red blood cells. They are used to treat anemia due to end stage kidney disease, chemotherapy, major surgery, or certain treatments in HIV/AIDS.
USD3480.00
Add To Cart
Popular Product Keywords
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
Search For: Erythropoietin Stimulating Agents
Total: 3 records, 1 pages
According to our (Global Info Research) latest study, the global Erythropoietin Stimulating Agents market size was valued at USD 9197.8 million in 2023 and is forecast to a readjusted size of USD 12120 million by 2030 with a CAGR of 4.0% during review period.
USD3480.00
Add To Cart
Erythropoiesis-stimulating agents (ESA) are medications which stimulate the bone marrow to make red blood cells. They are used to treat anemia due to end stage kidney disease, chemotherapy, major surgery, or certain treatments in HIV/AIDS.
USD4480.00
Add To Cart
Erythropoiesis-stimulating agents (ESA) are medications which stimulate the bone marrow to make red blood cells. They are used to treat anemia due to end stage kidney disease, chemotherapy, major surgery, or certain treatments in HIV/AIDS.
USD3480.00
Add To Cart
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
-
Insight into the industry market information
-
Analyze market development needs
-
Prospects for future development
-
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>